Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - mvnsiv239gagpoi
1
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Biological/Research Material for HIV Vaccine Research
Offered for licensing is a recombinant attenuated vaccinia virus, MVA, that expresses SIV 239gagpol. The materials can be used for research purposes and in particular in the area of HIV/AIDS vaccines. Plasmid insertion vector pJH-4, containing the foreign gene SIV 239 GagPol controlled by vaccinia early/late promoter, inserts into del III of attenuated...
Published: 10/28/2024
|
Inventor(s):
Linda Wyatt
,
Bernard Moss
Keywords(s):
239gagpol
,
ACXXXX
,
AXXXXX
,
DC5XXX
,
DCXXXX
,
DXXXXX
,
EXPRESSES
,
Gene
,
MVA/SIV239gagpol
,
MVNSIV239gagpoi
,
PJH4
,
recombinant
,
RESEARCH MATERIAL
,
SIV
,
SIV239gagpol
,
That
,
virus
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Vaccines